• Fluo-4 AM Calcium Assay Kit for Scaffold Studies

  2026-08-22

  Use live-cell calcium dynamics to connect electrospun scaffold fiber density with annulus fibrosus cell behavior. This workflow shows how the Fluo-4 AM Calcium Assay Kit can complement endpoint matrix analysis, support mechanotransduction studies, and scale toward receptor-focused screening.

• Chloroquine Diphosphate: From Flux to Translation

  2026-08-21

  Chloroquine Diphosphate is more than an autophagy reagent: it is a strategic perturbation tool for separating autophagosome formation, lysosomal clearance, cell-cycle control, and innate immune signaling. This article connects cancer-model applications with the HBsAg–TBK1 findings reported in Cell Death and Disease and outlines a more rigorous path from assay readouts to translational decisions.

• Mubritinib (TAK 165): Target-to-Assay Guide

  2026-08-20

  Mubritinib (TAK 165) is more than a historical HER2 inhibitor: it is a mechanistic probe of mitochondrial complex I, OXPHOS dependence, and protein binding. This guide translates its HSA interaction data into more interpretable AML, PEL, and cancer biology assays.

• UK-5099 for Whole-Blood Immunometabolism

  2026-08-20

  UK-5099, also known as PF-1005023, lets researchers test how mitochondrial pyruvate entry shapes cytokine responses without broadly removing extracellular glucose. This practical guide connects standardized whole-blood stimulation with mitochondrial respiration, insulinoma-cell assays, and glucose homeostasis studies while emphasizing controls, dose design, and troubleshooting.

• Canagliflozin and Mitochondria in Diabetic Kidney Cells

  2026-08-19

  Trentin-Sonoda and colleagues show that Canagliflozin improves mitochondrial network architecture and bioenergetic performance in proximal tubular cells from hypertensive–diabetic mice. The sex-dependent findings extend SGLT2 inhibitor research beyond glucose lowering and provide a mechanistic framework for studying renal protection in diabetic kidney disease.

• Elobixibat Hydrate: From IBAT to Translational Insight

  2026-08-19

  Elobixibat hydrate offers a compelling model of compartment-focused pharmacology: local ileal bile acid transporter inhibition can reshape colonic signaling, motility, and metabolic readouts without requiring high systemic exposure. This thought-leadership article connects IBAT biology with peristaltic-reflex research and provides a practical framework for translational validation.

• Sulfo-Cy3 azide for Neurodevelopmental Mapping

  2026-08-18

  Sulfo-Cy3 azide combines aqueous compatibility with bright orange-red fluorescence for labeling alkyne-bearing biomolecules, including oligonucleotides and potential EdU-based birthdating assays. This guide translates a rat claustrum development study into practical Click Chemistry fluorescent labeling, imaging, and troubleshooting workflows.

• Berberine Hydrochloride: A Causal Assay Map

  2026-08-18

  Berberine hydrochloride connects AMPK-centered metabolism with microbiome, tuft-cell, and osteoimmune biology. This article presents a causal assay framework for separating direct cellular effects from gut-mediated mechanisms in metabolic and bone research.

• UK-5099: A Mechanistic Lens on Immunometabolism

  2026-08-17

  UK-5099 (PF-1005023) is a mitochondrial pyruvate carrier inhibitor for connecting substrate transport with cellular phenotype. This article presents a decision framework for applying it across mitochondrial metabolism research, immune assays, and glucose-homeostasis studies without confusing transport blockade with global glycolytic inhibition.

• Fludarabine Workflows for Oncology Research

  2026-08-17

  Fludarabine provides a practical way to connect DNA replication stress with cell-cycle and apoptosis readouts in leukemia and multiple myeloma models. This guide covers formulation, dose-response design, mechanistic validation, genotype-aware assay planning, and troubleshooting for reproducible bench studies.

• HBTU for Precision Peptide Synthesis

  2026-08-16

  HBTU streamlines carboxylic acid activation for rapid, high-yield peptide bond formation in solid phase and solution workflows. Its practical value is especially clear when building enzyme-responsive peptide amphiphiles, where sequence fidelity, low racemization risk, and reproducible coupling directly influence downstream self-assembly assays.

• ML216 BLM Helicase Inhibitor Workflow Guide

  2026-08-15

  ML216 enables mechanism-focused interrogation of BLM-dependent DNA repair, from helicase assays and sister chromatid exchange to cell proliferation and chemotherapy-sensitization studies. This workflow emphasizes target controls, solvent discipline, and careful interpretation when extending BLM findings to WRN- or MSI-driven cancer models.

• Mc-Val-Cit-PABC-PNP ADC Linker Workflow

  2026-08-14

  Mc-Val-Cit-PABC-PNP is a cathepsin-cleavable ADC peptide linker for research workflows investigating payload release after lysosomal processing. This guide covers solvent handling, conjugation setup, QC, and limitations; the material is not intended for aqueous formulation, diagnostic use, or medical and therapeutic applications.

• RIPA Lysis Buffer (Strong) for Bone Protein Workflows

  2026-08-14

  Build reproducible bone-cell and tissue lysates for Western blotting, immunoprecipitation, and signaling studies with a stringent detergent system. This workflow connects prenatal dexamethasone research to practical sample handling, inhibitor control, and assay-specific optimization.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-13

  Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR inhibitors at substantially lower concentrations than a wild-type yeast background. The system distinguishes TOR1-dependent growth inhibition and provides a practical first-pass screen, while also showing that several tested compounds, including canagliflozin, produced no detectable TOR-inhibitory phenotype under the study conditions.

8355 records 1/557 page Next 12345 下5页 Last page